Concepedia

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

Giuseppe Viale, MM Regan, Patrizia Dell’Orto, Mauro G. Mastropasqua, Eugenio Maiorano, Blake B. Rasmussen, Gaëtan MacGrogan, JF Forbes, Robert Paridaens, Marco Colleoni,

Annals of Oncology · 2011 · 104 citations · 18 references

DOIFull text

Open access

Concepts

References

18

Molecular portraits of human breast tumours

Charles M. Perou, Thérese Sørlie, Michael B. Eisen et al. · Nature · 2000 · 16.3K citations

, , +14

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Thérese Sørlie, Charles M. Perou, Robert Tibshirani et al. · Proceedings of the National Academy of Sciences · 2001 · 10.9K citations · Full text

, , +16

Repeated observation of breast tumor subtypes in independent gene expression data sets

Thérese Sørlie, Robert Tibshirani, Joel S. Parker et al. · Proceedings of the National Academy of Sciences · 2003 · 5.4K citations · Full text

, , +17

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

Maggie C.U. Cheang, Stephen Chia, David Voduc et al. · JNCI Journal of the National Cancer Institute · 2009 · 2.2K citations · Full text

, , +17

A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer

New England Journal of Medicine · 2005 · 1.6K citations · Full text

, , +9